Wang Chien-Hao, Yang Jai-Sing, Chen Chao-Jung, Su San-Hua, Yu Hsin-Yuan, Juan Yu-Ning, Chiu Yu-Jen, Ho Tsung-Jung
Department of Chinese Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Tzu Chi Med J. 2024 Mar 26;36(2):152-165. doi: 10.4103/tcmj.tcmj_267_23. eCollection 2024 Apr-Jun.
The protective effects and related mechanisms of Jing-Si herbal tea (JSHT) were investigated in cellular damage mediated by pro-inflammatory cytokines, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-α, on normal human lung fibroblast by multiomic platform analysis.
The high-throughput target was analyzed using pharmacophore models by BIOVIA Discovery Studio 2022 with ingenuity pathway analysis software. To assess cell viability, the study utilized the MTT assay technique. In addition, the IncuCyte S3 ZOOM System was implemented for the continuous monitoring of cell confluence of JSHT-treated cytokine-injured HEL 299 cells. Cytokine concentrations were determined using a Quantibody Human Inflammation Array. Gene expression and signaling pathways were determined using next-generation sequencing.
high-throughput target analysis of JSHT revealed ingenuity in canonical pathways and their networks. Glucocorticoid receptor signaling is a potential signaling of JSHT. The results revealed protective effects against the inflammatory cytokines on JSHT-treated HEL 299 cells. Transcriptome and network analyses revealed that induction of helper T lymphocytes, TNFSF12, NFKB1-mediated relaxin signaling, and G-protein coupled receptor signaling play important roles in immune regulatory on JSHT-treated cytokine-injured HEL 299 cells.
The findings from our research indicate that JSHT holds promise as a therapeutic agent, potentially offering advantageous outcomes in treating virus infections through various mechanisms. Furthermore, the primary bioactive components in JSHT justify extended research in antiviral drug development, especially in the context of addressing coronavirus.
通过多组学平台分析,研究荆丝凉茶(JSHT)对由促炎细胞因子(包括白细胞介素(IL)-1β、IL-6和肿瘤坏死因子-α)介导的正常人肺成纤维细胞损伤的保护作用及相关机制。
使用BIOVIA Discovery Studio 2022的药效团模型和 Ingenuity Pathway Analysis软件进行高通量靶点分析。为评估细胞活力,本研究采用MTT检测技术。此外,使用IncuCyte S3 ZOOM系统连续监测JSHT处理的细胞因子损伤的HEL 299细胞的细胞汇合度。使用定量抗体人炎症阵列测定细胞因子浓度。使用下一代测序确定基因表达和信号通路。
JSHT的高通量靶点分析揭示了其在经典通路及其网络中的独特之处。糖皮质激素受体信号传导是JSHT的潜在信号传导。结果显示JSHT对处理过的HEL 299细胞的炎性细胞因子具有保护作用。转录组和网络分析表明,辅助性T淋巴细胞的诱导、TNFSF12、NFKB1介导的松弛素信号传导和G蛋白偶联受体信号传导在JSHT处理的细胞因子损伤HEL 299细胞的免疫调节中起重要作用。
我们的研究结果表明,JSHT有望成为一种治疗药物,可能通过多种机制在治疗病毒感染方面产生有利结果。此外,JSHT中的主要生物活性成分证明了在抗病毒药物开发方面进行深入研究的合理性,特别是在应对冠状病毒的背景下。